Meeting the challenge of cardiovascular care in the new National Health Service.
The National Service Framework (NSF) established coronary heart disease as a priority area for the government and for the National Health Service (NHS). In the three and a half years since its launch, good progress has been made and the NSF is already delivering real improvements for patients, demonstrated by a near 25% reduction in the death rate from circulatory diseases. Prescribing of cardiovascular drugs for secondary prevention has increased, acute myocardial infarction is being treated more promptly, and there is improved access to revascularisation procedures. However, there is still a notable class differential in cardiovascular deaths. There has been exponential growth in use of statins but the drugs are still not being used to optimum effect. Heart failure has now been identified as a priority for action.
Boyle
R
R
Department of Health, Wellington House, 133-155 Waterloo Road, London SE1 8UG, UK. roger.boyle@doh.gsi.gov.uk
D003325:Coronary Care Units; D003327:Coronary Disease / Q000517:prevention & control*; D006297:Health Services Accessibility; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000517:prevention & control; D013222:State Medicine
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors